Co-Amoxiclav Tablets Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP manufactures Co-Amoxiclav Tablets for bacterial infections involving the respiratory tract, urinary tract, dental region, skin tissues, and ENT system. The formulation is frequently prescribed in sinusitis, bronchitis, urinary infections, dental abscesses, and mixed bacterial conditions requiring enhanced antibacterial coverage.

Amoxicillin acts by inhibiting bacterial cell wall synthesis, while Clavulanic Acid protects the antibiotic from beta-lactamase enzyme degradation produced by resistant bacterial strains. This antibacterial combination is widely utilized in outpatient therapies involving recurrent or difficult bacterial infections.

Genliva Wellness LLP specializes in oral antibiotic contract manufacturing in Gujarat supplying broad-spectrum antibacterial formulations for pharmaceutical distributors, institutional buyers, and international export markets.

Co-Amoxiclav Tablets are formulated for resistant and mixed bacterial infection treatment.

Broad-spectrum amoxicillin and clavulanate combination
Frequently prescribed in respiratory bacterial conditions
Activity against beta-lactamase producing organisms
Optimized tablet formulation for oral administration
Manufactured using premium pharmaceutical ingredients
Intended for outpatient antibacterial therapies

This formulation is administered in respiratory, dental, and urinary bacterial infection management.

Treatment of sinusitis and bronchitis
Management of urinary tract infections
Prescribed in dental abscess bacterial conditions
Utilized in skin and ENT infection therapies
Targets resistant bacterial pathogens
Frequently selected in oral antibacterial protocols

Co-Amoxiclav Tablets deliver extended antibacterial coverage for recurrent bacterial infections.

Valuable in dental and respiratory infection treatment
Effective against resistant bacterial strains
Frequently preferred in mixed bacterial conditions
Broad antibacterial reach across multiple infections
Convenient oral antibacterial therapy option
Maintains strong amoxicillin-clavulanate performance